{"version":"1.0","type":"rich","title":"SI-B003 + Izalontamab Brengitecan for carcinoma, transitional cell","provider_name":"What came of it?","provider_url":"https://staging.whatcameofit.com/","html":"<iframe src=\"https://staging.whatcameofit.com/embed/si-b003-izalontamab-brengitecan--carcinoma-transitional-cell\" title=\"SI-B003 + Izalontamab Brengitecan for carcinoma, transitional cell\" width=\"440\" height=\"420\" style=\"border:0;max-width:100%\" loading=\"lazy\"></iframe>","width":440,"height":420,"thumbnail_url":"https://staging.whatcameofit.com/brand-card.png?v=b7e2e5c93907","thumbnail_width":1200,"thumbnail_height":630,"cache_age":86400}